FDA Warns Alkermes on Vivitrol Ads

]]>(MedPage Today) -- WASHINGTON--A Vivitrol ad prompted an FDA warning to drug maker Alkermes that it failed to disclose the product's most serious risks.Vivitrol is an extended-release injection formulation of naltrexone and is one of three...